日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extremely Low-Frequency and Low-Intensity Electromagnetic Field Technology (ELF-EMF) Sculpts Microtubules

极低频低强度电磁场技术 (ELF-EMF) 塑造微管

Alexandra Lobyntseva, Maram Ganaiem, Yanina Ivashko-Pachima, Colin J Barnstable, Batsheva Weisinger, Ana Parabucki, Yaron Segal, Esther Shohami, Illana Gozes

The thrombin receptor (PAR1) is associated with microtubules, mitosis and process formation in glioma cells

凝血酶受体 (PAR1) 与胶质瘤细胞中的微管、有丝分裂和突起形成有关

Valery Golderman, Shany Guly Gofrit, Yanina Ivashko-Pachima, Illana Gozes, Joab Chapman, Efrat Shavit-Stein

NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms

NAP(达武奈肽):神经保护性 ADNP 候选药物可穿透细胞核,解释多效性机制

Maram Ganaiem, Nina D Gildor, Shula Shazman, Gidon Karmon, Yanina Ivashko-Pachima, Illana Gozes

Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk

表征不同 ADNP 突变体的不同损伤揭示了异常的细胞质-核串扰

Maram Ganaiem, Gidon Karmon, Yanina Ivashko-Pachima, Illana Gozes

Tauopathy in the young autistic brain: novel biomarker and therapeutic target

年轻自闭症患者大脑中的 Tau 蛋白病变:新型生物标志物和治疗靶点

Iris Grigg, Yanina Ivashko-Pachima #, Tom Aharon Hait #, Vlasta Korenková, Olga Touloumi, Roza Lagoudaki, Anke Van Dijck, Zlatko Marusic, Mirna Anicic, Jurica Vukovic, R Frank Kooy, Nikolaos Grigoriadis, Illana Gozes

A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP

新型微管-Tau 关联增强剂和神经保护候选药物:Ac-SKIP

Yanina Ivashko-Pachima, Illana Gozes

NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies

NAP(达武奈肽)与动态 3 重复 Tau 的优先相互作用解释了特定 tauopathies 中的差异保护

Yanina Ivashko-Pachima, Maya Maor-Nof, Illana Gozes

The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities

ADNP 衍生肽 NAP 调节微管蛋白池:对神经营养和神经保护活动的影响

Saar Oz, Yanina Ivashko-Pachima, Illana Gozes